1-155910878-C-T

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The ENST00000609492.1(RIT1):​c.-117G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000479 in 1,585,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000050 ( 0 hom. )

Consequence

RIT1
ENST00000609492.1 5_prime_UTR

Scores

2
1
14
Splicing: ADA: 0.00004223
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.0850

Publications

0 publications found
Variant links:
Genes affected
RIT1 (HGNC:10023): (Ras like without CAAX 1) This gene encodes a member of a subfamily of Ras-related GTPases. The encoded protein is involved in regulating p38 MAPK-dependent signaling cascades related to cellular stress. This protein also cooperates with nerve growth factor to promote neuronal development and regeneration. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
RIT1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07235709).
BP6
Variant 1-155910878-C-T is Benign according to our data. Variant chr1-155910878-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 181520.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000502 (72/1433334) while in subpopulation MID AF = 0.000523 (3/5740). AF 95% confidence interval is 0.000321. There are 0 homozygotes in GnomAdExome4. There are 38 alleles in the male GnomAdExome4 subpopulation. Median coverage is 39. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 72 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIT1NM_006912.6 linkc.-43-74G>A intron_variant Intron 1 of 5 ENST00000368323.8 NP_008843.1
RIT1NM_001256821.2 linkc.8G>A p.Arg3Lys missense_variant, splice_region_variant Exon 1 of 6 NP_001243750.1
RIT1NM_001256820.2 linkc.-3+365G>A intron_variant Intron 1 of 4 NP_001243749.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIT1ENST00000368323.8 linkc.-43-74G>A intron_variant Intron 1 of 5 1 NM_006912.6 ENSP00000357306.3

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000132
AC:
26
AN:
196632
AF XY:
0.000169
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000542
Gnomad ASJ exome
AF:
0.000110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000606
Gnomad OTH exome
AF:
0.000383
GnomAD4 exome
AF:
0.0000502
AC:
72
AN:
1433334
Hom.:
0
Cov.:
39
AF XY:
0.0000534
AC XY:
38
AN XY:
711006
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32454
American (AMR)
AF:
0.000489
AC:
19
AN:
38818
Ashkenazi Jewish (ASJ)
AF:
0.0000390
AC:
1
AN:
25642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37710
South Asian (SAS)
AF:
0.0000954
AC:
8
AN:
83878
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52020
Middle Eastern (MID)
AF:
0.000523
AC:
3
AN:
5740
European-Non Finnish (NFE)
AF:
0.0000337
AC:
37
AN:
1097596
Other (OTH)
AF:
0.0000673
AC:
4
AN:
59476
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152200
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41448
American (AMR)
AF:
0.0000655
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000604
ExAC
AF:
0.0000933
AC:
11

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 26, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Arg3Lys variant in RIT1 has not been previously reported in individuals wi th Noonan spectrum disorders, but has been identified in 8/49232 chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs 730881012). This variant is located in the last base of the exon, which is part of the 5? splice region. Computational tools do not suggest an impact to splicin g or an impact to the protein. However, this information is not predictive enoug h to rule out pathogenicity. In summary, the clinical significance of the p.Arg3 Lys variant is uncertain. -

Noonan syndrome 8 Benign:1
Aug 23, 2020
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
9.1
DANN
Benign
0.91
Eigen
Benign
0.055
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.34
T
M_CAP
Benign
0.0076
T
MetaRNN
Benign
0.072
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.085
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
0.20
N
REVEL
Benign
0.0080
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.11
MutPred
0.36
Gain of methylation at R3 (P = 0.0063);
MVP
0.44
MPC
0.79
ClinPred
0.043
T
GERP RS
-1.3
PromoterAI
-0.081
Neutral
gMVP
0.75
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000042
dbscSNV1_RF
Benign
0.062
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs730881012; hg19: chr1-155880669; API